Recursion Pharmaceuticals, Inc. (RXRX) vs Vir Biotechnology, Inc. (VIR)

• Recursion Pharmaceuticals, Inc. RXRX 3.57 ▲ +0.56%
• Vir Biotechnology, Inc. VIR 13.12 ▼ −0.23%

Recursion Pharmaceuticals, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Recursion Pharmaceuticals, Inc. and Vir Biotechnology, Inc. are of similar size ($2.3B and $2.2B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against 56.2%. Vir Biotechnology, Inc. has the higher net margin (−61.0% vs −697.1%) and the higher return on invested capital (−30.3% vs −88.5%). Across the 18 metrics below, Vir Biotechnology, Inc. leads on 16 and Recursion Pharmaceuticals, Inc. on 2.